Preview

Вестник дерматологии и венерологии

Расширенный поиск

Системная терапия больных андрогенетической алопецией

https://doi.org/10.25208/0042-4609-2015-0-1-41-45

Полный текст:

Аннотация

Представлены данные литературы по эффективности применения системной терапии в лечении андрогенной алопеции у женщин и мужчин

Об авторах

И. Н. Кондрахина
ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России
Россия


А. Н. Мареева
ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России
Россия


Список литературы

1. Tosti A., Piraccini B., Sisti A. et al. Hair loss in women. Minerva Ginecol 2009; 61: 445-452.

2. Kelekci K.H, Kelekci S. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. J Dermatolog Treat. 2012 Jun; 23 (3): 177-83.

3. Vexiau P., Chaspoux C., Boudou P. et al. Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial. Br J Dermatol 146: 992-999, 2002.

4. Brzezinska-Wcislo L. Assessment of efficacy of Diane-35 in androgenetic feminine alopecia. Wiad Lek, 2003. 56: 202-5.

5. Lucky A.W., Piacquadio D.J., Ditre C.M. et al. A randomized, placebocontrolled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol, 2004, 50: 541-53.

6. Алейникова Н.Л., Мазитова Л.П., Чернуха Г.Е. Сравнительная эффективность антиандрогенных препаратов в лечении андрогенетической алопеции женщин репродуктивного возраста. Экспериментальная и клиническая дерматокосметология 2004; 6: 38-40.

7. Мареева А.Н. Оптимизация тактики ведения женщин репродуктивного возраста с андрогенетической алопецией с учетом уровня стероидных гормонов и молекулярно-генетических факторов. Автореферат диссертации на соискание ученой степени кандидата медицинских наук. М. 2013.

8. Sinclair R., Wewerinke M., Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol, 2005, 152: 466-73.

9. Rathnayake D., Sinclair R. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatol Clin. 2010 Jul; 28 (3): 611-8.

10. Carmina E., Lobo N. Treatment of hyperandrogenic alopecia in women. Fertil Steril 2003, 79: 91-5.

11. Paradisi R., Porcu E., Fabbri R. et al. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother. 2011 Apr; 45 (4): 469-75.

12. Ong K., F. de Zegher, López-Bermejo A. et al. Flutamide-metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype. European Journal of Endocrinology, 2007: Vol. 157, Issue 5: 661-668.

13. Kaufman K.D., Olsen E.A., Whiting D. et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol, 1998, 39: 578-89.

14. Price V.H., Roberts J.L., Hordinsky M. et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000; 43: 768-76.

15. Shum K.W., Cullen D.R., Messenger A.G. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol 2002; 47: 733-9.

16. Thai K.E., Sinclair R.D. Finasteride for female androgenetic alopecia. Br J Dermatol 2002; 147: 812-13.

17. Trüeb R.M. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology 2004, 209: 202-7.

18. Oliveira-Soares R., Maia e Silva J., Peres Correia M. Finasteride 5 mg/day reatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women. Int J Trichology. 2013 Jan-Mar; 5 (1): 22-25.

19. Boersma I.H., Oranje A.P., Grimalt R. et al. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2014 Nov-Dec; 80 (6): 521-5.

20. Vexiau P., Chaspoux C., Boudou P. et al. Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res. 2000 Dec; 292 (12): 598-604.

21. Shapiro J., Kaufman K.D. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Invest Derm Symp Proc 2003: 8: 20-23.

22. Kaufman K.D., Girman C.J., Round E.M. et al. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients. Eur J Dermatol 2008: 18: 407-411.

23. Kaufman K.D, Rotonda J., Shah A.K. et al. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol 2008: 18: 400-406.

24. Olsen E.A., Hordinsky M., Whiting D. et al. Dutasteride Alopecis Research Team. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006: 55: 1014-1023.

25. Eun H.C., Kwon O.S., Yeon J.H. et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebocontrolled, phase III study. J Am Acad Dermatol. 2010 Aug; 63 (2): 252-8.

26. Gubelin Harcha W., Barboza Martinez J., Tsai T.F. et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014 Mar; 70 (3): 489-498.

27. Jung J.Y., Yeon J.H., Choi J.W. et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatol. 2014 Nov; 53 (11): 1351-7.


Для цитирования:


Кондрахина И.Н., Мареева А.Н. Системная терапия больных андрогенетической алопецией. Вестник дерматологии и венерологии. 2015;(1):41-45. https://doi.org/10.25208/0042-4609-2015-0-1-41-45

For citation:


Kondrakhina I.N., Mareeva A.N. Systemic therapy of androgenic alopecia. Vestnik dermatologii i venerologii. 2015;(1):41-45. (In Russ.) https://doi.org/10.25208/0042-4609-2015-0-1-41-45

Просмотров: 204


ISSN 0042-4609 (Print)
ISSN 2313-6294 (Online)